Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Frontiers in Medicine
|
March 10, 2018
Posttransplant Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model
Leland Metheny, Saada Eid, Karen Lingas, et al.
JCO Clinical Cancer Informatics
|
May 6, 2022
Machine Learning to Predict Risk of Relapse Using Cytologic Image Markers in Patients With Acute Myeloid Leukemia Posthematopoietic Cell Transplantation
Sara Arabyarmohammadi, Patrick Leo, Vidya Sankar Viswanathan, et al.
Research Square
|
July 28, 2023
Vactosertib, a novel TGF-β1 type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myeloma
Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, et al.
Leukemia & Lymphoma
|
June 16, 2026
Efficacy of skin microvasculature C5b-9 and MASP2 deposition in transplant-associated thrombotic microangiopathy
Michael Daunov, John Sumodi, Nikki Agarwal, et al.
Bone Marrow Transplantation
|
February 7, 2020
Treatment-related mortality following autologous hematopoietic stem cell transplantation is unaffected by timing of G-CSF administration
Naveed Ali, Brenda Cooper, Benjamin Tomlinson, et al.
Nature Communications
|
August 27, 2024
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial
Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 29, 2021
Diffuse Large B Cell Lymphoma in Patients 80 Years and Older: Worse Survival After Treatment Without Increased Relapse Rates
Madison Keenan, Akiva Diamond, Kirsten Boughan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 23, 2020
A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia
Benjamin K Tomlinson, Molly M Gallogly, Donna M Kane, et al.
Research Square
|
October 4, 2023
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial
Ehsan Malek, Jeries Kort, Leland Metheny, et al.
Cancers
|
February 6, 2021
Socioeconomic Factors and Survival of Multiple Myeloma Patients
Kamal Chamoun, Amin Firoozmand, Paolo Caimi, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Frontiers in Medicine
|
March 10, 2018
Posttransplant Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model
Leland Metheny, Saada Eid, Karen Lingas, et al.
JCO Clinical Cancer Informatics
|
May 6, 2022
Machine Learning to Predict Risk of Relapse Using Cytologic Image Markers in Patients With Acute Myeloid Leukemia Posthematopoietic Cell Transplantation
Sara Arabyarmohammadi, Patrick Leo, Vidya Sankar Viswanathan, et al.
Research Square
|
July 28, 2023
Vactosertib, a novel TGF-β1 type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myeloma
Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, et al.
Leukemia & Lymphoma
|
June 16, 2026
Efficacy of skin microvasculature C5b-9 and MASP2 deposition in transplant-associated thrombotic microangiopathy
Michael Daunov, John Sumodi, Nikki Agarwal, et al.
Bone Marrow Transplantation
|
February 7, 2020
Treatment-related mortality following autologous hematopoietic stem cell transplantation is unaffected by timing of G-CSF administration
Naveed Ali, Brenda Cooper, Benjamin Tomlinson, et al.
Nature Communications
|
August 27, 2024
The TGFβ type I receptor kinase inhibitor vactosertib in combination with pomalidomide in relapsed/refractory multiple myeloma: a phase 1b trial
Ehsan Malek, Priyanka S Rana, Muthulekha Swamydas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 29, 2021
Diffuse Large B Cell Lymphoma in Patients 80 Years and Older: Worse Survival After Treatment Without Increased Relapse Rates
Madison Keenan, Akiva Diamond, Kirsten Boughan, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
February 23, 2020
A Phase II Study of Midostaurin and 5-Azacitidine for Untreated Elderly and Unfit Patients With FLT3 Wild-type Acute Myelogenous Leukemia
Benjamin K Tomlinson, Molly M Gallogly, Donna M Kane, et al.
Research Square
|
October 4, 2023
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial
Ehsan Malek, Jeries Kort, Leland Metheny, et al.
Cancers
|
February 6, 2021
Socioeconomic Factors and Survival of Multiple Myeloma Patients
Kamal Chamoun, Amin Firoozmand, Paolo Caimi, et al.
Page
of 6